Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rethink Compliance is a private compliance services and e-learning company that provides ethics and compliance training, advisory services, codes of conduct, and program analytics for enterprise customers. The company serves organizations across multiple industries, including pharmaceuticals, medical devices, and biotech, but it is not itself a biotech, pharma, or healthcare company. Its offerings center on modern compliance content, custom and library-based training, governance/risk/compliance advisory work, and communications tools designed to improve program effectiveness. Founded in 2015 by Kirsten Liston, Rethink positions itself as a specialist partner to in-house compliance teams rather than a developer of therapeutic products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rethink Compliance.